The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
PLoS One. 2023 Oct 5;18(10):e0292456. doi: 10.1371/journal.pone.0292456. eCollection 2023.
Previous work strongly implicated Collagen 17a1 (Col17a1) as a potent genetic modifier of junctional epidermolysis bullosa (JEB) caused by a hypomorphic mutation (Lamc2jeb) in mice. The importance of the noncollagenous domain (NC4) of COLXVII was suggested by use of a congenic reduction approach that restricted the modifier effect to 2-3 neighboring amino acid changes in that domain. The current study utilizes TALEN and CRISPR/Cas9 induced amino acid replacements and in-frame indels nested to NC4 to further investigate the role of this and adjoining COLXVII domains both as modifiers and primary risk effectors. We confirm the importance of COLXVI AA 1275 S/G and 1277 N/S substitutions and utilize small nested indels to show that subtle changes in this microdomain attenuate JEB. We further show that large in-frame indels removing up to 1482 bp and 169 AA of NC6 through NC1 domains are surprisingly disease free on their own but can be very potent modifiers of Lamc2jeb/jeb JEB. Together these studies exploiting gene editing to functionally dissect the Col17a1 modifier demonstrate the importance of epistatic interactions between a primary disease-causing mutation in one gene and innocuous 'healthy' alleles in other genes.
先前的工作强烈表明,胶原蛋白 17a1(Col17a1)是导致连接性表皮松解症(JEB)的潜在遗传修饰因子,这种突变在小鼠中为低功能突变(Lamc2jeb)。COLXVII 的非胶原结构域(NC4)的重要性是通过利用同系减少方法来证明的,该方法将修饰因子的效应限制在该结构域中的 2-3 个相邻氨基酸变化内。本研究利用 TALEN 和 CRISPR/Cas9 诱导的氨基酸替换和 NC4 内的框内缺失,进一步研究了该结构域和相邻 COLXVII 结构域作为修饰因子和主要风险效应因子的作用。我们证实了 COLXVI AA 1275 S/G 和 1277 N/S 替换的重要性,并利用小的嵌套缺失来表明该微域的细微变化可减轻 JEB。我们进一步表明,通过 NC1 结构域去除多达 1482 bp 和 169 AA 的 NC6 内的大框内缺失本身就可以无病,但可以成为 Lamc2jeb/jeb JEB 的非常有效的修饰因子。这些利用基因编辑来对 Col17a1 修饰因子进行功能分解的研究表明,一个基因中的主要致病突变与其他基因中的无害“健康”等位基因之间的上位性相互作用非常重要。